SNAIL gene inhibited by hypoxia-inducible factor 1α (HIF-1α) in epithelial ovarian cancer

Pengnan Zhang1, Yanmei Liu2, Youji Feng3

  • 1Obstetrics and Gynecology Hospital of Fudan University, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, PR China.

Insights

Hypoxia increases Hypoxia-Inducible Factor 1-alpha (HIF-1α) and SNAIL expression in ovarian cancer cells, promoting invasion. HIF-1α acts as an upstream regulator of SNAIL, suggesting a key pathway in epithelial ovarian cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Epithelial ovarian cancer (EOC) metastasis is a complex process involving gene expression changes.
  • Hypoxia-Inducible Factor 1-alpha (HIF-1α) and SNAIL are implicated in cancer progression.
  • The precise relationship between HIF-1α and SNAIL in EOC remains to be fully elucidated.

Purpose of the Study:

  • To investigate the relationship between HIF-1α and SNAIL gene expression in an epithelial ovarian cancer cell line.
  • To determine the role of the HIF-1α-SNAIL pathway in EOC invasion and metastasis.

Main Methods:

  • Epithelial ovarian cancer cells were treated with hypoxia, hypoxia plus rapamycin, and control conditions.
  • Gene and protein expression of HIF-1α, SNAIL, and E-cadherin were analyzed using RT-PCR, real-time PCR, and western blotting.
  • RNA interference (siRNA) was employed to assess the regulatory relationship between HIF-1α and SNAIL.

Main Results:

  • Hypoxia increased HIF-1α protein and SNAIL mRNA expression while decreasing E-cadherin expression in EOC cells.
  • Prolonged hypoxia enhanced EOC cell invasion; rapamycin partially inhibited HIF-1α and SNAIL expression but did not affect invasion.
  • siRNA targeting HIF-1α suppressed SNAIL expression, whereas siRNA targeting SNAIL did not affect HIF-1α levels.

Conclusions:

  • HIF-1α acts as an upstream regulator of SNAIL in epithelial ovarian cancer.
  • The HIF-1α-SNAIL-E-cadherin pathway is crucial for EOC invasion and metastasis.
  • Targeting the HIF-1α-SNAIL pathway may offer therapeutic strategies for epithelial ovarian cancer.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.9K